Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
B cells from rheumatoid arthritis patients show important alterations in the expression of CD86 and FcgammaRIIb, which are modulated by anti-tumor necrosis factor therapy.
Catalán D, Aravena O, Sabugo F, Wurmann P, Soto L, Kalergis AM, Cuchacovich M, Aguillón JC; Millenium Nucleus on Immunology and Immunotherapy P-07-088-F. Catalán D, et al. Arthritis Res Ther. 2010;12(2):R68. doi: 10.1186/ar2985. Epub 2010 Apr 15. Arthritis Res Ther. 2010. PMID: 20398308 Free PMC article.
The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism.
Soto L, Sabugo F, Catalan D, Wurmann P, Cermenatti T, Gatica H, Aravena O, Salazar L, Aguillón JC, Cuchacovich M. Soto L, et al. Among authors: catalan d. Clin Rheumatol. 2011 Mar;30(3):391-5. doi: 10.1007/s10067-011-1679-4. Epub 2011 Jan 14. Clin Rheumatol. 2011. PMID: 21234628
Anti-TNF therapy in patients with rheumatoid arthritis decreases Th1 and Th17 cell populations and expands IFN-γ-producing NK cell and regulatory T cell subsets.
Aravena O, Pesce B, Soto L, Orrego N, Sabugo F, Wurmann P, Molina MC, Alfaro J, Cuchacovich M, Aguillón JC, Catalán D. Aravena O, et al. Among authors: catalan d. Immunobiology. 2011 Dec;216(12):1256-63. doi: 10.1016/j.imbio.2011.07.006. Epub 2011 Jul 7. Immunobiology. 2011. PMID: 21840621 Free article.
Treatment with Dexamethasone and Monophosphoryl Lipid A Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers Tolerogenic Features.
García-González PA, Schinnerling K, Sepúlveda-Gutiérrez A, Maggi J, Hoyos L, Morales RA, Mehdi AM, Nel HJ, Soto L, Pesce B, Molina MC, Cuchacovich M, Larrondo ML, Neira Ó, Catalán DF, Hilkens CM, Thomas R, Verdugo RA, Aguillón JC. García-González PA, et al. Front Immunol. 2016 Oct 25;7:458. doi: 10.3389/fimmu.2016.00458. eCollection 2016. Front Immunol. 2016. PMID: 27826300 Free PMC article.
Tumour necrosis factor (TNF)alpha -308 G/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritis.
Cuchacovich M, Soto L, Edwardes M, Gutierrez M, Llanos C, Pacheco D, Sabugo F, Alamo M, Fuentealba C, Villanueva L, Gatica H, Schiattino I, Salazaro L, Catalan D, Valenzuela O, Salazar-Onfray F, Aguillón JC. Cuchacovich M, et al. Among authors: catalan d. Scand J Rheumatol. 2006 Nov-Dec;35(6):435-40. doi: 10.1080/03009740600904284. Scand J Rheumatol. 2006. PMID: 17343250
Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
Salazar L, Aravena O, Abello P, Escobar A, Contreras-Levicoy J, Rojas-Colonelli N, Catalán D, Aguirre A, Zúñiga R, Pesce B, González C, Cepeda R, Cuchacovich M, Molina MC, Salazar-Onfray F, Delgado M, Toes RE, Aguillón JC. Salazar L, et al. Among authors: catalan d. Ann Rheum Dis. 2008 Sep;67(9):1235-41. doi: 10.1136/ard.2007.072199. Epub 2007 Dec 4. Ann Rheum Dis. 2008. PMID: 18056756
50 results